# The Arteriovenous Vascular (AV) ACCESS Trial

Study · id `cardio:ct-nct04646226` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04646226](<https://clinicaltrials.gov/study/NCT04646226>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04646226

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 103 participants.

## Technical summary

Registry record NCT04646226. Randomized; no masking; primary purpose treatment. Start 2022-08-18 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 103 participants (enrolled count; ClinicalTrials.gov record NCT04646226, source copy `cardio:ctgov-nct04646226-2026-06-01`, retrieved 2026-10-26)
- Started: 2022-08-18 (actual) (ClinicalTrials.gov record NCT04646226, source copy `cardio:ctgov-nct04646226-2026-06-01`, retrieved 2026-10-26)
- Primary completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT04646226, source copy `cardio:ctgov-nct04646226-2026-06-01`, retrieved 2026-10-26)
- Completion: 2027-08-31 (anticipated) (ClinicalTrials.gov record NCT04646226, source copy `cardio:ctgov-nct04646226-2026-06-01`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04646226, source copy `cardio:ctgov-nct04646226-2026-06-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04646226-2026-06-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Arteriovenous Vascular (AV) ACCESS Trial
- Condition: End-Stage Kidney Disease
- Condition: Hemodialysis Complication
- Intervention (Device): AV graft
- Intervention (Procedure): surgical intervention for creation of a fistula
- Lead sponsor: Wake Forest University Health Sciences
- Lead sponsor class: OTHER
- Collaborator: National Institute on Aging (NIA)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Wake Forest University Health Sciences (`cardio:wake-forest-health-sciences`)
- Registry lists this organization as a collaborator: National Institute on Aging (`cardio:nia`)

## Provenance

Content hash: 2430ff8a83b00a68b912eac006b851d7c64fdfacab9cf3f60009e930a5f6d916
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
